SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has filed its Form 10-Q with the Securities and Exchange Commission. Fresenius Kabi Pharmaceuticals Holding, Inc., acquired APP Pharmaceuticals, Inc., on September 10, 2008. The Form 10-Q details the Company’s unaudited financial statements for the quarter ending September 30, 2009.
